ARCHIVES

Phase III Alimta Trial Fails To Extend Progression-Free Survival Without Grade 4 Adverse Events

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

Women Are Less Active After A Diagnosis of Breast Cancer

March 28, 2003

Separation Will Make Interaction Easier; AACR President Says

June 26, 1992

Institute Of Medicine: External Experts Should Vet Large Projects, Report Says.

June 20, 2003

Opioid Pain Reliever Approved With Risk Reduction Plan

July 31, 2009

In Brief: Eyre ACS President, Freeman President Elects, Kathleen Horsch Chairman, Davis Heads ASTRO

November 20, 1987

Final Results from CLEOPATRA Phase III Trial Show Perjeta Increased OS 15.7 Months

September 26, 2014